Follow
Vijay Nema
Vijay Nema
National Institute of Translational Virology and AIDS Research (formerly: ICMR-NARI)
Verified email at nariindia.org
Title
Cited by
Cited by
Year
ACE2 and TMPRSS2 polymorphisms in various diseases with special reference to its impact on COVID-19 disease
HO Singh, R Choudhari, V Nema, AA Khan
Microbial pathogenesis 150, 104621, 2021
992021
Isolation and characterization of heat resistant enterotoxigenic Staphylococcus aureus from a food poisoning outbreak in Indian subcontinent
V Nema, R Agrawal, DV Kamboj, AK Goel, L Singh
International Journal of Food Microbiology 117 (1), 29-35, 2007
992007
Role of microRNAs in type 2 diabetes and associated vascular complications
J Banerjee, V Nema, Y Dhas, N Mishra
Biochimie 139, 9-19, 2017
542017
Tuberculosis diagnostics: Challenges and opportunities
V Nema
Lung India 29 (3), 259-266, 2012
472012
Detection of Viable Toxigenic Vibrio cholerae from Environmental Water Sources by Direct Cell Duplex PCR Assay
AK Goel, AK Tamrakar, V Nema, DV Kamboj, L Singh
World Journal of Microbiology and Biotechnology 21, 973-976, 2005
312005
The burden of respiratory viruses and their prevalence in different geographical regions of India: 1970–2020
R Waghmode, S Jadhav, V Nema
Frontiers in Microbiology 12, 723850, 2021
292021
HIV-associated neurotoxicity: the interplay of host and viral proteins
S Jadhav, V Nema
Mediators of Inflammation 2021, 2021
242021
Loop-mediated isothermal amplification: Beyond microbial identification
RR Kundapur, V Nema
Cogent Biology 2 (1), 1137110, 2016
242016
Impact of GSTM1, GSTT1 and GSTP1 gene polymorphism and risk of ARV-associated hepatotoxicity in HIV-infected individuals and its modulation
GRR Singh HO, Lata S, Angadi M, Bapat S, Pawar J, Nema V, Ghate MV, Sahay S
Pharmacogenomics J, 2015
22*2015
PknB remains an essential and a conserved target for drug development in susceptible and MDR strains of M. Tuberculosis
A Gupta, SK Pal, D Pandey, NA Fakir, S Rathod, D Sinha, S SivaKumar, ...
Annals of clinical microbiology and antimicrobials 16, 1-10, 2017
172017
Modulating catalytic activity of human topoisomerase II α enzyme by fluorescent gold nanoclusters
A Dubey, V Singh, PK Doharey, MP Sk, SK Samanta, V Nema, B Sharma, ...
International Journal of Biological Macromolecules 170, 523-531, 2021
162021
Detection of Beijing strains of MDR M. tuberculosis and their association with drug resistance mutations in katG, rpoB, and embB genes
A Gupta, P Sinha, V Nema, PK Gupta, P Chakraborty, S Kulkarni, ...
BMC infectious diseases 20, 1-7, 2020
162020
Current status of probiotics for prevention and management of gastrointestinal cancers
AA Khan, V Nema, Z Khan
Expert Opinion on Biological Therapy 21 (3), 413-422, 2021
152021
Heterologous expression of staphylococcal enterotoxin B (seb) gene for antibody production
D Vrat Kamboj, V Nema, A Kumar Pandey, A Kumar Goel, L Singh
Electronic Journal of Biotechnology 9 (5), 0-0, 2006
152006
The role and future possibilities of next-generation sequencing in studying microbial diversity
V Nema
Microbial diversity in the genomic era, 611-630, 2019
142019
IL-1RN and IL-1β polymorphism and ARV-associated hepatotoxicity
HO Singh, D Samani, V Nema, MV Ghate, RR Gangakhedkar
Mediators of inflammation 2018, 2018
132018
Exploration of freely available web-interfaces for comparative homology modelling of microbial proteins
V Nema, SK Pal
Bioinformation 9 (15), 796, 2013
122013
Elucidation of Antiviral and Antioxidant Potential of C-Phycocyanin against HIV-1 Infection through In Silico and In Vitro Approaches
P Jadaun, C Seniya, SK Pal, S Kumar, P Kumar, V Nema, SS Kulkarni, ...
Antioxidants 11 (10), 1942, 2022
92022
APOBEC3B deletion impacts on susceptibility to acquire HIV‐1 and its advancement among individuals in western India
HO Singh, SD Marathe, S Nain, V Nema, MV Ghate, RR Gangakhedkar
Apmis 124 (10), 881-887, 2016
92016
Anti-retroviral drugs for HIV: Old and new
K Vaidya, A Kadam, V Nema
Austin J. HIV AIDS Res 3, 1026, 2016
92016
The system can't perform the operation now. Try again later.
Articles 1–20